RAD50 and cancer: Pathogenic variants in RAD50 was shown to be associated with genomic instability assessed by cytogenetic analysis of peripheral blood T-lymphocytes26, suggesting an effect for RAD50 haploinsufficiency on genomic integrity and susceptibility to cancer.